Abstract
We report an unusual pregnancy with a complete hydatiform mole coexisting with a normal fetus and placenta. This report stresses the importance of a correct diagnosis and the dilemmas the clinician is faced with when managing such a case. Malignant trophoblastic disease occurs in 55% of complete hydatiform mole and fetus. Two-thirds require combination chemotherapy.
MeSH terms
-
Abortifacient Agents, Nonsteroidal / therapeutic use
-
Abortion, Induced / methods
-
Adult
-
Antimetabolites, Antineoplastic / therapeutic use
-
Diagnosis, Differential
-
Female
-
Humans
-
Hydatidiform Mole, Invasive / diagnosis*
-
Hydatidiform Mole, Invasive / drug therapy
-
Methotrexate / therapeutic use
-
Misoprostol / therapeutic use
-
Pregnancy
-
Pregnancy, Multiple*
-
Trophoblastic Neoplasms / diagnosis
-
Twins
-
Uterine Neoplasms / diagnosis*
-
Uterine Neoplasms / drug therapy
Substances
-
Abortifacient Agents, Nonsteroidal
-
Antimetabolites, Antineoplastic
-
Misoprostol
-
Methotrexate